Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

4.00USD
4:31pm BST
Change (% chg)

$-0.05 (-1.23%)
Prev Close
$4.05
Open
$4.10
Day's High
$4.15
Day's Low
$3.95
Volume
4,665
Avg. Vol
37,595
52-wk High
$8.80
52-wk Low
$3.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.688
Sep '17 0.00 -0.727
Jun '17 0.00 -0.989
Mar '17 0.00 -0.798
FY 2016 Dec '16 0.00 -0.880
Sep '16 0.00 -0.879
Jun '16 0.00 -0.847
Mar '16 0.00 -0.709
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.26 0.78 0.00 0.39
Quarter Ending Sep-18 3 0.25 0.75 0.00 0.39
Year Ending Dec-18 6 0.51 3.06 0.00 0.38
Year Ending Dec-19 5 1.10 4.00 0.00 0.25
Earnings (per share)
Quarter Ending Jun-18 6 -0.64 -0.53 -0.74 -0.73
Quarter Ending Sep-18 6 -0.67 -0.54 -0.88 -0.75
Year Ending Dec-18 7 -2.88 -2.25 -4.08 -3.26
Year Ending Dec-19 5 -2.50 -2.05 -3.03 -2.64
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.16 45.72
P/E Low - Last 5 Yrs. -- 91.58 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) -- 110.88 5.71
Price to Book (MRQ) 2.01 13.58 5.37
Price to Tangible Book (MRQ) 2.01 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 83.64 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.71 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.06 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -16.70 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago -21.07 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 7.49 5.30 2.98
LT Debt to Equity (MRQ) 14.96 22.96 12.18
Total Debt to Equity (MRQ) 16.05 24.62 16.45
Interest Coverage (TTM) -- -99.34 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.72 10.96
Operating Margin (TTM) -- -718.49 4.73
Operating Margin - 5 Yr. Avg. -- -596.03 6.40
Pre-Tax Margin (TTM) -- -692.96 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.39 6.81
Net Profit Margin (TTM) -- -694.19 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.24 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,625,667 846,830,423
Net Income/Employee (TTM) -944,400 2,971,219 99,616,130
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -66.20 -1.11 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -72.93 1.58 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -77.58 2.41 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -42.36 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cidara Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 83.55%
# of Holders: 63
Total Shares Held: 17,353,995
3 Mo. Net Change: 98,844
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 4
# Reduced Positions: 2
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.